BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26686248)

  • 1. The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
    Dutta S; Krause A; Vosberg S; Herold T; Ksienzyk B; Quintanilla-Martinez L; Tizazu B; Chopra M; Graf A; Krebs S; Blum H; Greif PA; Vetter A; Metzeler K; Rothenberg-Thurley M; Schneider MR; Dahlhoff M; Spiekermann K; Zimber-Strobl U; Wolf E; Bohlander SK
    Leukemia; 2016 May; 30(5):1166-76. PubMed ID: 26686248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.
    Caudell D; Harper DP; Novak RL; Pierce RM; Slape C; Wolff L; Aplan PD
    Blood; 2010 Feb; 115(6):1194-203. PubMed ID: 20007546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L.
    Okada Y; Jiang Q; Lemieux M; Jeannotte L; Su L; Zhang Y
    Nat Cell Biol; 2006 Sep; 8(9):1017-24. PubMed ID: 16921363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
    Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
    Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients.
    Bohlander SK; Muschinsky V; Schrader K; Siebert R; Schlegelberger B; Harder L; Schemmel V; Fonatsch C; Ludwig WD; Hiddemann W; Dreyling MH
    Leukemia; 2000 Jan; 14(1):93-9. PubMed ID: 10637482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
    Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
    Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and molecular characterization of CALM/AF10fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia.
    Carlson KM; Vignon C; Bohlander S; Martinez-Climent JA; Le Beau MM; Rowley JD
    Leukemia; 2000 Jan; 14(1):100-4. PubMed ID: 10637483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.
    Conway AE; Scotland PB; Lavau CP; Wechsler DS
    Blood; 2013 Jun; 121(23):4758-68. PubMed ID: 23487024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice.
    Lange AP; Almeida LY; Araújo Silva CL; Scheucher PS; Chahud F; Krause A; Bohlander SK; Rego EM
    Braz J Med Biol Res; 2019; 52(6):e8424. PubMed ID: 31141090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice.
    Caudell D; Zhang Z; Chung YJ; Aplan PD
    Cancer Res; 2007 Sep; 67(17):8022-31. PubMed ID: 17804713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
    Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
    Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes.
    Dik WA; Brahim W; Braun C; Asnafi V; Dastugue N; Bernard OA; van Dongen JJ; Langerak AW; Macintyre EA; Delabesse E
    Leukemia; 2005 Nov; 19(11):1948-57. PubMed ID: 16107895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.
    Chen L; Deshpande AJ; Banka D; Bernt KM; Dias S; Buske C; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
    Leukemia; 2013 Apr; 27(4):813-22. PubMed ID: 23138183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia.
    Deshpande AJ; Cusan M; Rawat VP; Reuter H; Krause A; Pott C; Quintanilla-Martinez L; Kakadia P; Kuchenbauer F; Ahmed F; Delabesse E; Hahn M; Lichter P; Kneba M; Hiddemann W; Macintyre E; Mecucci C; Ludwig WD; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
    Cancer Cell; 2006 Nov; 10(5):363-74. PubMed ID: 17097559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts.
    Narita M; Shimizu K; Hayashi Y; Taki T; Taniwaki M; Hosoda F; Kobayashi H; Nakamura H; Sadamori N; Ohnishi H; Bessho F; Yanagisawa M; Ohki M
    Br J Haematol; 1999 Jun; 105(4):928-37. PubMed ID: 10554802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.
    Fu JF; Liang ST; Huang YJ; Liang KH; Yen TH; Liang DC; Shih LY
    Int J Cancer; 2017 Mar; 140(5):1159-1172. PubMed ID: 27859216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
    Archangelo LF; Gläsner J; Krause A; Bohlander SK
    Oncogene; 2006 Jul; 25(29):4099-109. PubMed ID: 16491119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.
    Asnafi V; Radford-Weiss I; Dastugue N; Bayle C; Leboeuf D; Charrin C; Garand R; Lafage-Pochitaloff M; Delabesse E; Buzyn A; Troussard X; Macintyre E
    Blood; 2003 Aug; 102(3):1000-6. PubMed ID: 12676784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocytic leukemia with CALM/AF10 rearrangement showing mediastinal emphysema.
    Nakamura F; Maki K; Arai Y; Nakamura Y; Mitani K
    Am J Hematol; 2003 Feb; 72(2):138-42. PubMed ID: 12555219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias.
    Conway AE; Haldeman JM; Wechsler DS; Lavau CP
    Leukemia; 2015 Feb; 29(2):423-32. PubMed ID: 25027513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.